3,4-methylenedioxyamphetamine has been researched along with Developmental Disabilities in 2 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kearney, PM | 1 |
| Griffin, T | 1 |
| Capitanio, MA | 1 |
| Kirkpatrick, JA | 1 |
2 other studies available for 3,4-methylenedioxyamphetamine and Developmental Disabilities
| Article | Year |
|---|---|
Between joy and sorrow: being a parent of a child with developmental disability.
Topics: Adaptation, Psychological; Adult; Attitude to Health; Child; Child, Preschool; Denial, Psychological | 2001 |
Widening of the cranial sutures: a roentgen observation during periods of accelerated growth in patients treated for deprivation dwarfism.
Topics: Age Determination by Skeleton; Arm; Body Height; Body Weight; Child; Child Behavior Disorders; Child | 1969 |